Stephen Hoge
President · Moderna, Inc.
IndividualSelling only26 10b5-1 trades
- 2024
- Sep 16, 2026
- 18
Filings (90d)
3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Stephen Hoge files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Stephane Bancel - $28.72M in MRNA purchases and sales in the last 12 months
- James M. Mock - $4.69M in MRNA purchases and sales in the last 12 months
- Shannon Thyme Klinger - $1.39M in MRNA purchases and sales in the last 12 months
- Noubar Afeyan - $434K in MRNA purchases and sales in the last 12 months
- Abbas Hussain - $265K in MRNA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Stephen Hoge?
Stephen Hoge is a corporate insider, tracked as President of Moderna, Inc. (MRNA). InsiderAlpha holds 18 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Stephen Hoge submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Stephen Hoge been buying or selling stock?
Recorded transactions: 0 open-market purchases and 9 open-market sales ($28.47M) across all tracked filings.
